Skip to main content
OpenTrials

Clinical trial condition

Uveal Diseases

Explore clinical trials studying Uveal Diseases. Study availability and eligibility vary by location and protocol.

802 public trials 112 recruiting studies
Refine in advanced search Browse all conditions

Uveal Diseases trial results

Recruiting

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

NCT04855435

Conditions
Advanced Solid Tumor, Cutaneous Melanoma, Eye Diseases, +21 more
Locations
  • Herlev and Gentofte Hospital, Center for Cancer Research Herlev, Denmark
  • Institut Catalá de Oncologia - Hospital Duran i Reynals. Barcelona, Spain
  • Fundacion Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (FJD) Madrid, Spain
  • Centro Integral Oncológico Clara Campal (CIOCC) Madrid, Spain
View Trial Details
Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

NCT03947385

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +27 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • San Francisco Oncology Associates San Francisco, California, United States
  • SCRI - Denver Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Recruiting

Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

NCT06395285

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +10 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Duke Eye Center - Duke University Hospital Durham, North Carolina, United States
  • John A. Moran Eye Center - University of Utah Health Salt Lake City, Utah, United States
  • Save Sight Institute - University of Sydney Eye Hospital Sydney, New South Wales, Australia
View Trial Details
Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT03686124

Conditions
Adnexal Diseases, Cancer, Disease Attributes, +35 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 21 locations
View Trial Details

Related conditions